Table 2.
Antibodies used to evaluate CLA and CD162 in leprosy lesions
| Antibody specificity | Clone | Isotype | Source1 |
|---|---|---|---|
| CLA | HECA-452 | Rat IgM | BD Pharmingen |
| CD3 | B355·1 | Mouse IgG3 | Biomeda Corp. |
| CD68 | Y1/82 A | Mouse IgG2b | BD Pharmingen |
| CD162 | KPL-1 | Mouse IgG1 | BD Pharmingen |
| Isotype control | MOPC-21 | Mouse IgG1 | Sigma |
| Isotype control | MOPC-141 | Mouse IgG2b | Sigma |
| Isotype control | R4-22 | Rat IgM | BD Pharmingen |
BD Pharmingen, San Diego, CA; Biomeda Corp., Foster City, CA; Sigma, St Louis, MO.